About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: November 2007
Weekly Roundup – 11/30/07
It is hard to believe we sit on the cusp of December and 2008. And to celebrate the new year, we are going to have a bunch of primaries that are going to keep our focus on a year long … Continue reading
Posted in Weekly Roundup
1 Comment
Brief Update on Behind the Counter
A few weeks ago, on November 15, I reported on the public meeting held by the FDA to elicit input on the idea that drugs might have a new class beyond prescription and over-the-counter, called behind-the-counter, dispensed and, in essence, … Continue reading
Posted in FDA Policy
Comments Off on Brief Update on Behind the Counter
Dr. David Acheson
Last week, I had the good fortune to sit down with Dr. David Acheson, Assistant Commissioner for Food Safety at the Food and Drug Administration. I had wanted to meet him ever since reading about him in the Washington Post … Continue reading
Posted in Podcast
Comments Off on Dr. David Acheson
Rudy Giuliani – Where Do the Candidates Stand – Part 5
Because the Democrats seem to dominate the beginning of the alphabet, this is the first opportunity I’ve had to review a Republican in this on-going series. With the Democrats so far, we have seen each – Biden, Clinton, Dodd and … Continue reading
Posted in Current Affairs
Comments Off on Rudy Giuliani – Where Do the Candidates Stand – Part 5
Formal Dispute Resolution and the FDA – Revisiting the Issue
Given the holiday week, there is no Weekly Roundup this week, but my eye did catch an interesting tidbit that made me want to re-visit the issue of appealing an FDA decision. I last wrote about it on July 17 … Continue reading
Posted in FDA Policy
Comments Off on Formal Dispute Resolution and the FDA – Revisiting the Issue